Kymera Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Chiniara Ellen | Chief Legal Officer | Award / Grant | 21,755 | — | — | 55,960 | Mar 1, 2024 |
| Gollob Jared | Chief Medical Officer | Sale | 400 | $45.00 | $18,000 | 74,709 | Feb 27, 2024 |
| Albers Jeffrey W. | — | Sale | 4,385 | $39.05 | $171,234 | — | Feb 21, 2024 |
| Gollob Jared | Chief Medical Officer | Sale | 7,398 | $36.09 | $266,994 | 74,709 | Feb 9, 2024 |
| Albers Jeffrey W. | — | Option Exercise | 10,000 | $10.34 | $103,400 | 10,000 | Jan 23, 2024 |
| Chiniara Ellen | Chief Legal Officer | Sale | 3,295 | $22.58 | $74,401 | 34,205 | Jan 4, 2024 |
| Mainolfi Nello | Chief Executive Officer | Option Exercise | 9,000 | $2.08 | $18,720 | 615,570 | Jan 2, 2024 |
| Mainolfi Nello | Chief Executive Officer | Option Exercise | 17,632 | $2.08 | $36,675 | 606,570 | Nov 3, 2023 |
| BVF II GP LLC | — | Purchase | 26,772 | $11.64 | $311,626 | 284,526 | Nov 2, 2023 |
| Mainolfi Nello | Chief Executive Officer | Option Exercise | 12,000 | $2.08 | $24,960 | 586,570 | Aug 8, 2023 |
| Jacobs Bruce N. | Chief Financial Officer | Option Exercise | 10,000 | $2.08 | $20,800 | 115,035 | Jun 2, 2023 |
| Chadwick Jeremy G | Chief Operating Officer | Award / Grant | 33,333 | — | — | 33,333 | May 22, 2023 |
| Caughey Elaine | Chief Business Officer | Sale | 550 | $30.88 | $16,984 | 19,150 | Mar 2, 2023 |
| Gollob Jared | Chief Medical Officer | Award / Grant | 18,750 | — | — | 76,007 | Mar 2, 2023 |
| Jacobs Bruce N. | Chief Financial Officer | Sale | 314 | $31.40 | $9,860 | 104,568 | Mar 1, 2023 |
| Atlas Venture Opportunity Fund I, L.P. | — | Sale | 21,592 | $30.29 | $654,022 | 890,148 | Jan 12, 2023 |
| BIOTECHNOLOGY VALUE FUND II LP | — | Purchase | 2,985 | $31.24 | $93,251 | 2,494,688 | Jan 11, 2023 |
| Booth Bruce | — | Sale | 77,128 | $30.29 | $2,336,207 | 4,968,114 | Jan 11, 2023 |
| Chiniara Ellen | Chief Legal Officer | Award / Grant | 37,500 | — | — | 37,500 | Jan 3, 2023 |
| Atlas Venture Associates Opportunity I, LLC | — | Sale | 112,819 | $30.28 | $3,416,159 | 5,252,744 | Dec 14, 2022 |
| Booth Bruce | — | Sale | 15,324 | $32.33 | $495,425 | 926,180 | Dec 14, 2022 |
| Mainolfi Nello | Chief Executive Officer | Option Exercise | 10,000 | $2.08 | $20,800 | 573,700 | Dec 8, 2022 |
| Booth Bruce | — | Sale | 21,085 | $30.00 | $632,550 | 1,001,417 | Nov 2, 2022 |
| Atlas Venture Associates Opportunity I, L.P. | — | Sale | 96,581 | $30.02 | $2,899,362 | 5,440,875 | Nov 2, 2022 |
| Atlas Venture Fund X, L.P. | — | Sale | 71,135 | $30.00 | $2,134,050 | 5,691,877 | Nov 1, 2022 |
| Booth Bruce | — | Sale | 3,727 | $31.08 | $115,835 | 5,537,456 | Oct 31, 2022 |
| Jacobs Bruce N. | Chief Financial Officer | Option Exercise | 10,000 | $2.08 | $20,800 | 81,279 | Oct 21, 2022 |
| Jacobs Bruce N. | Chief Financial Officer | Option Exercise | 10,000 | $2.08 | $20,800 | 71,279 | Oct 17, 2022 |
| Mainolfi Nello | Chief Executive Officer | Option Exercise | 27,676 | $2.08 | $57,566 | 561,931 | Oct 17, 2022 |
| BIOTECHNOLOGY VALUE FUND II LP | — | Purchase | 233,362 | $26.00 | $6,067,412 | 1,861,290 | Aug 22, 2022 |
| BVF PARTNERS L P/IL | — | Purchase | 90,372 | $14.21 | $1,284,186 | 1,601,575 | May 26, 2022 |
| BIOTECHNOLOGY VALUE FUND L P | — | Purchase | 5,883 | $14.00 | $82,362 | 2,036,860 | May 20, 2022 |
| BVF INC/IL | — | Purchase | 55,210 | $19.26 | $1,063,345 | 2,030,977 | May 5, 2022 |
| Gollob Jared | Chief Medical Officer | Option Exercise | 9,792 | $2.08 | $20,367 | 57,257 | May 4, 2022 |
| Mainolfi Nello | Chief Executive Officer | Option Exercise | 20,000 | $2.08 | $41,600 | 502,199 | May 3, 2022 |
| Jacobs Bruce N. | Chief Financial Officer | Option Exercise | 20,000 | $2.08 | $41,600 | 60,814 | May 3, 2022 |
| Jacobs Bruce N. | Chief Financial Officer | Award / Grant | 13,300 | — | — | 40,814 | Mar 1, 2022 |
| Gollob Jared | Chief Medical Officer | Award / Grant | 12,600 | — | — | 37,257 | Mar 1, 2022 |
| Caughey Elaine | Chief Business Officer | Award / Grant | 7,000 | — | — | 7,000 | Mar 1, 2022 |
| BVF INC/IL | — | Purchase | 58,042 | $38.33 | $2,224,750 | 1,880,187 | Jan 31, 2022 |
| Biotechnology Value Trading Fund OS LP | — | Purchase | 114,726 | $37.76 | $4,332,054 | 1,343,743 | Jan 24, 2022 |
| Mainolfi Nello | Chief Executive Officer | Option Exercise | 10,000 | $2.08 | $20,800 | 482,199 | Jan 14, 2022 |
| Jacobs Bruce N. | Chief Financial Officer | Option Exercise | 10,000 | $2.08 | $20,800 | 27,514 | Jan 14, 2022 |
| Jacobs Bruce N. | Chief Financial Officer | Sale | 6,427 | $51.21 | $329,127 | 26,087 | Jan 12, 2022 |
| Mainolfi Nello | Chief Executive Officer | Sale | 347 | $55.05 | $19,102 | 472,199 | Jan 10, 2022 |
| Mainolfi Nello | Chief Executive Officer | Option Exercise | 8,000 | $2.08 | $16,640 | 472,199 | Dec 16, 2021 |
| Jacobs Bruce N. | Chief Financial Officer | Sale | 7,713 | $53.31 | $411,180 | 19,801 | Dec 3, 2021 |
| Jacobs Bruce N. | Chief Financial Officer | Option Exercise | 10,000 | $2.08 | $20,800 | 17,256 | Nov 23, 2021 |
| Gollob Jared | Chief Medical Officer | Sale | 15,134 | $61.50 | $930,741 | 44,633 | Nov 1, 2021 |
| Mainolfi Nello | Chief Executive Officer | Sale | 9,369 | $56.82 | $532,347 | 475,138 | Oct 8, 2021 |